Nuclear factor of kappa B (NF-jB) transcription factors are critical regulators of T-cell activation and survival. The relative contribution of individual NF-jB members to these processes remains elusive. We investigated the role of RelA in the regulation of CD8 T-cell activation. We overexpressed, in mature CD8 T cells, a transactivation domain-deficient RelA molecule (p65TAD). We show that p65TAD forms homo-and heterodimers with p50 that bind jB sites and selectively inhibit RelA-dependent transactivation. Expression of p65TAD does not affect initial activation or cell cycle progression but induces the death of activated CD8 T cells in vitro and in vivo. However, the long-term survival of resting effector CD8 T cells seems not to be affected by p65TAD expression. Collectively, our results indicate that RelA is a critical regulator of survival of proliferating CD8 T cells but may be dispensable for the survival of resting effector T cells.
Introduction
The nuclear factor of kappa B (NF-kB) family of transcription factors is composed of NF-kB1 (p50/p105), NF-kB2 (p52/ p100), RelA (p65), cRel and RelB that bind to kB motifs upon homo-or heterodimerization. 1 Under normal conditions, NFkB dimers are retained in the cytoplasm by the IkB inhibitory protein that following activation is phosphorylated and degraded, thus releasing the NF-kB complexes that can translocate to the nucleus. 1 In addition, post-translational modifications contribute to transcriptional activity of NF-kB complexes. [2] [3] [4] NF-kB-binding sites are present in many genes involved in T-cell activation and survival, in cell cycle control and T-cell effector function. As a consequence, NF-kB regulates multiple aspects of T-cell activation. Indeed, mature CD4 þ or CD8 þ T cells isolated from mice transgenic for a degradationresistant IkBa, which completely blocks the nuclear translocation of p65/p50 and cRel complexes, present a proliferative defect and an increased susceptibility to activation-induced apoptosis that is independent of IL-2/IL-2Ra gene regulation. 5, 6 IL-2 production was also impaired in T cells expressing such an inhibitor of IkBa. Furthermore, activation and cell cycle progression were not affected by adenoviral expression of the same constitutive inhibitor of IkBa in mature T cells, but T-cell death occurred following S phase entry. 7 NF-kB may also regulate the survival of mature resting T cells. 5, [8] [9] [10] Despite the critical role of NF-kB in T-cell activation and survival, the relative contribution of individual NF-kB members in these processes has remained elusive. In mature T cells, Tcell receptor (TCR) and CD28 stimulation primarily induce nuclear translocation of p65/p50 heterodimers while homoand heterodimers of cRel with p65 and p50 are less abundant and their appearance may be delayed. 11 Despite this predominance, loss of RelA has only a moderate effect on T-cell activation as does cRel deficiency. Thus, RelA À/À or p50 À/À T cells present a moderate proliferative defect, without increased apoptosis or impairment in IL-2 production. 12, 13 On the other hand, cRel-deficient T cells do not produce IL-2 following activation and, as a consequence, present a significant proliferative defect in vitro. [13] [14] [15] [16] However, CD4 T cells deficient for both cRel and p50 show a major impairment of T-cell activation and cell cycle entry, reduced IL-2 and CD25 expression and increased apoptosis. 17 The mild phenotype of individual knock out mice as compared to that of mice deficient for both p50, cRel and p65 containing complexes suggested that deficiency in one subunit might be compensated by other NF-kB complexes. In addition, the observed phenotype of NF-kB-deficient T cells may in part result from perturbed T-cell development. 5, 18, 19 In this study, we re-evaluated the role of RelA in CD8 T-cell activation. To overcome side effects that may occur during T-cell development and the problem of possible compensation by other NF-kB dimers, we overexpressed in mature CD8 T cells, a truncated RelA molecule (p65TAD, p65 transactivation domain deficient) that lacks the two transactivation domains (TAD) normally present in RelA but retains the Rel homology domain (RHD). We show here that TAD-deficient RelA selectively inhibits RelA-dependent transactivation. When overexpressed in CD8 T cells, TAD-deficient RelA induces premature cell death of activated CD8 T cells both in vitro and in vivo but does not impair initial T-cell activation. Collectively, our results show that RelA is a critical regulator of survival of activated CD8 T cells but may be dispensable for the survival of resting effector CD8 T cells.
Results

Expression of transactivation domain-deficient RelA in CD8 T cells
To evaluate the role of RelA in CD8 T-cell activation and survival, we wished to generate a molecule that, when expressed in mature T cells, would selectively inhibit RelAdependent transactivation. Previous studies have indicated that TAD-deficient RelA molecules may act as transdominant inhibitors of NF-kB-dependent transactivation. 20, 21 We therefore engineered a similarly truncated RelA molecule (p65TAD) lacking the two transactivation domains normally present in RelA while maintaining the RHD, the nuclear localization sequence and the protein kinase A (PKA) phosphorylation site. Such truncated RelA molecules would thus maintain homo-and heterodimerization, interaction with histone deacetylases and CBP/p300 and DNA-binding activity, but should lack transactivation properties. 2, 3, 22 To determine whether indeed p65TAD may act as an inhibitor of kB-dependent transcription, we coexpressed in 293 T cells p65TAD or, as control, full-length RelA (p65FL) and an NF-kB reporter construct in which expression of the firefly luciferase gene is under the control of NF-kB sites from the Igk enhancer element. As expected, p65TAD did not show significant NFkB transcriptional activity in this assay (Figure 1 ). Furthermore, p65TAD inhibited in a dose-dependent fashion the transcriptional activity of cotransfected p65FL indicating that p65TAD inhibits RelA-dependent transactivation (Figure 1) .
To study the role of RelA in T-cell responses to antigenic stimulation, we generated retroviruses that express either p65TAD or p65FL using a bicistronic retroviral vector containing an IRES-GFP that permits the isolation of infected cells by FACS sorting. The CD8 T cells were isolated from Dé siré TCR transgenic mice (referred hereafter as CD8
þ Des þ T cells) and are specific for the alloantigen H-2K b . The different retroviral constructs were used to infect 22 h in vitro activated CD8 þ Des þ T cells. Initial T-cell activation and G0 to G1 transition, therefore, proceed normally, in the absence of the transgene. Thus, p65TAD expression begins when nuclear translocation of the different NF-kB complexes is still high (not shown). Truncated RelA therefore likely competes with all endogenous NF-kB complexes induced by TCR and CD28 stimulation. Infection of CD8 þ Des þ T cells with the different retroviral constructs led to overexpression of the corresponding molecules to a comparable level without significant change in the level of expression of endogenous p65, p50 and cRel (Figure 2a) . We examined by EMSA whether p65TAD translocates to the nucleus of activated T cells and shows DNA-binding activity. Two complexes, N1 and N2, were detected in mock or p65FL-infected CD8
þ Des þ T cells (Figure 2b ). Supershift experiments with extracts from mockinfected cells indicated that the N1 complexes mainly contained p65 homo-and heterodimers with p50, while the N2 complexes correspond to p50 homodimers ( Figure 2b ). In contrast to mock-infected cells, CD8
þ Des þ T cells overexpressing p65FL demonstrated increased nuclear representation of the p65-containing N1 complexes, as compared to the N2 complex ( Figure 2b ). Nuclear extracts of CD8 þ Des þ T cells overexpressing p65TAD contain low level of N1 and predominantly express a faster migrating N3 complex (Figure 2b) . Despite numerous attempts, we did not succeed in separating the N2 and N3 complexes in p65TAD-infected cells. Expression of the N2 complex, although at low levels, is nevertheless suggested by the persistence of a complex with a mobility corresponding to the N2 complex in anti-p65 supershifts, which disappeared in anti-p50 supershifts (Figure 2b) . Generation of the N1 complex present in p65TAD-transfected cells was inhibited by anti-p65 and p50 Ab and only weakly by cRel-specific Ab. The N1 complex detected in CD8
þ Des þ T cells overexpressing p65TAD, thus likely corresponds to p65 and cRel homo-and heterodimers with p50. The anti-p65 Ab completely inhibited the generation of the N3 complex, which was only partially inhibited by antip50 Ab, suggesting that the N3 complex found in p65TAD-expressing CD8
þ Des þ T cells contains homo-and heterodimers of RelA with p50. The faster migration of the N3 complexes as compared to conventional p65-containing complexes indicates that they are exclusively composed of TAD-deficient RelA.
TAD-deficient RelA inhibits transactivation from some jB sites
The different NF-kB complexes have distinct DNA-binding specificity and affinities in vitro. 23 Some kB sequences within a defined promoter may thus be selective for some subunits in vivo. We therefore determined whether TAD-deficient RelA may inhibit selectively RelA-dependent transcription in CD8 T cells. We examined the regulation of 16 genes known to contain kB sites in their promoter sequences that bind RelAcontaining complexes in vitro and are expressed in CD8 T cells. [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] Further analysis of T cells with impaired NF-kB transactivation suggests, however, that these genes exhibit distinct kB-dependent expression. Based on these studies, we delineated five groups of genes that may be regulated by Figure 1 TAD-deficient RelA inhibits RelA-dependent transactivation. 293 T cells were transfected with the indicated amount (mg) of NF-kB-Luc plasmid together with a combination of empty vector (Mock), vector encoding for full length (p65FL) or TAD-deficient RelA (p65TAD), as indicated. Luciferase activity was read 24 h after transfection. The mean relative luciferase activity of three independent transfections performed in one representative experiment out of three performed is presented different NF-kB complexes in vivo. Group I genes p65, cRel and Bcl-2 are not affected in T cells expressing a degradation-resistant IkBa or deficient for both p50 and cRel and are thus likely not regulated by NF-kB in this cell type. 5, 17, 19 Expression of these genes is not downmodulated in CD8
þ Des þ T cells overexpressing p65TAD (Table 1) . Likewise, expression of cRel or Bcl-2 is not altered by p65FL overexpression ( Table 1 ). The increased level of p65 protein observed in p65FL-transfected cells reflects both endogenous and overexpressed transgenic RelA, which cannot be distinguished in this experimental system. The involvement of NF-kB in the regulation of group II genes is still unknown since expression of these genes in T cells with deregulated NF-kB transcriptional activity has not yet been evaluated. Within that group of molecules, only FasL expression is slightly downmodulated by p65TAD overexpression though p65FL has no effect on the expression of this molecule (Table 1 ). This slight effect of p65TAD suggests that RelA, although not essential, may potentiate either directly or indirectly the transcriptional activity of the complexes that bind to the FasL promoter. Among genes that are extinguished in T cells with impaired NF-kB activity, we found that expression of Bcl-x L is significantly reduced following p65TAD overexpression (Table 1 , group III). Genes that are repressed in cRel but not in RelA-deficient T cells were not significantly affected by p65TAD or p65FL overexpression (Table 1 , group IV). Finally, expression of IkBa and CD69, two genes that are tightly regulated by RelA, is significantly downmodulated in CD8
þ Des þ T cells transduced with p65TAD and upregulated in cells transduced with p65FL (Table 1 , group V and Figure 2a ). We confirmed that the effect of p65TAD on Bcl-x L , CD69 and IkBa expression was at the transcriptional level by showing that expression of the corresponding mRNA was reduced in CD8
þ Des þ T cells transduced with p65TAD as compared to that of mock or p65FL-expressing cells ( Table 1) .
The contrasting effect of p65TAD on the different genes analyzed suggests that transactivation domain-deficient RelA may selectively inhibit transcription from RelA-regulated kB sites.
Activated CD8
þ Des þ T cells overexpressing TAD-deficient RelA are short lived
We further evaluated the impact of p65TAD overexpression on T-cell responses in vitro. Thus, 22 h-activated CD8 þ Des þ T cells were infected with retroviral particles expressing truncated or full-length p65 or were mock infected, as controls. The GFP þ cells were FACS sorted 3 days postinfection and clonal expansion and cell death were evaluated, after an additional 48 h culture in IL-2. As shown before, expression of CD25 is comparable for the different infected populations ( Table 1) . Overexpression of p65FL had no effect on the expansion or survival of the CD8 þ Des þ T cells (Figure 3a and b) . In contrast, expression of p65TAD led to a global reduction of the number of CD8 þ Des þ T cells recovered at the end of the 48 h-culture period (Figure 3a) . This reduction in cell recovery was not due to cell cycle arrest but rather to increased cell death. Indeed, cell death was augmented for p65TAD-expressing CD8 T cells, which showed normal cell cycle entry or cell cycle progression (Figure 3b and c) . 
RelA controls the homeostatic proliferation of activated CD8 T cells in vivo
We further examined whether p65TAD may also affect T-cell expansion and/or survival in vivo. For this experiment, we analyzed the homeostatic proliferation of activated T cells in vivo. We adoptively transferred into irradiated hosts in vitro activated effector CD8
þ Des þ T cells that were infected with either one of the three different retroviral preparations 5 days before. We transferred the entire culture without sorting the GFP þ population. Expression of GFP permits direct analysis of the infected population, while the GFP negative population serves as an internal control for experimental variation. Since over 90% of in vitro activated CD8 T cells have lost expression of the lymph node homing receptor CD62L, they home to and remain in the spleen while fewer than 10% access the lymph node (not shown). We therefore only present the number of þ Des þ T cells was important between day 7 and 13 but stopped almost completely thereafter, as suggested by the limited increase in the number of CD8
þ Des þ T cells between day 13 and 21 ( Figure 4a) . The increase in the number of splenocytes and host CD8 T cells followed the same kinetics, indicating that by day 13 after transfer, the lymphoid compartment had repopulated and the homeostatic Protein expression level was determined by FACS staining, which showed a single homogeneous peak. The mean fluorescence intensity of mock and experimental samples was, therefore, measured and used to calculate the relative values.
d Protein expression was determined by FACS staining, which showed a bimodal distribution of positive and negative cells. The percentage of positive cells in mock or experimental samples was, therefore, used to calculate the relative value Role of RelA in controlling CD8 T-cell response I Mondor et al proliferation was ending. Collectively these observations suggested that, by this time point, transferred effector cells likely became resting cells. Importantly, the number of p65TAD-expressing CD8 T cells did not decline between day 14 and day 21, when homeostatic proliferation had ceased, suggesting that p65TAD has no effect on long-term survival of resting effector cells (Figure 4b ).
RelA controls the survival but not the early proliferation of in vivo activated CD8 T cells
We further examined the response of p65TAD-expressing CD8 T cells to antigen (Ag) stimulation in vivo. In contrast to homeostatic proliferation, Ag challenge induces a rapid proliferation of Ag-specific T cells. We could thus more clearly determine whether p65TAD may affect the proliferation or the survival of CD8 T cells in vivo.
We performed the same adoptive transfer experiment as described above, but in this case immunized some of the mice by intravenous injection of H-2K b -expressing LPS blasts, a condition that permits full activation of naive CD8 (Figure 5b ). The proliferation of T cells expressing the Mock or p65TAD constructs was comparable to that of the corresponding GFP À population, while expression of p65FL slightly increased cell proliferation (Figure 5b ). This conclusion is further evident when comparing the percentage of GFP þ cells detected in immunized and unimmunized mice, which is similar for the mock-or p65TAD-infected population and significantly increased for p65FL-infected cells (Figure 5a ). In addition, cell cycle progression was comparable for the three different populations (Figure 5c ). Therefore, as observed in vitro, RelA is not a critical regulator of the initial proliferation of Ag-stimulated T cells in vivo.
We next determined whether, as suggested by the previous observation (Figures 3 and 4) , RelA might regulate long-term survival of Ag-activated T cells in vivo. We performed the same experiment as described above, but analyzed the mice 7 days postimmunization. For both mock-and p65FL-infected populations, the percentage of GFP þ CD8 þ Des þ T cells was comparable in unimmunized and immunized animals, indicating that the Ag-induced proliferation of CD8 þ Des þ T cells was not affected by expression of either of these transgenes ( Figure 6 ). In contrast, the percentage of p65TAD-expressing CD8 þ Des þ T cells was significantly reduced in mice immunized with H-2K b -expressing APC as compared to nonimmunized controls, suggesting that when activated p65TAD-expressing CD8 T cells died ( Figure 6 ).
Expression of transactivation-deficient RelA thus has no significant effect on the in vivo proliferation but increases the Figure 4 Impaired homeostatic proliferation of p65TAD-expressing CD8 T cells. 22 h-activated CD8 þ Des þ T cells were infected with mock, p65FL or p65TAD-encoding retrovirus as described in Figure 2 . At day 5 postactivation, the infected CD8
þ Des þ T cells were collected and the total, unsorted population was adoptively transferred into irradiated syngeneic B10.BR mice. The percentage of CD8 þ Des þ GFP À (a) and CD8 þ Des þ GFP þ (b) cells present in the spleen of the different mice was determined at the indicated days posttransfer by FACS staining and the corresponding number of cells present in the spleen is shown. One experiment out of three with mean value and standard deviation of three mice is shown death of Ag-stimulated CD8 þ Des þ T cells. Collectively, these data strongly suggest that RelA critically regulates the survival of activated effector CD8 T cells.
Discussion
In this study, we evaluated the role of RelA in the regulation of CD8 T-cell activation. To overcome the possibility that other NF-kB complexes may compensate for RelA deficiency, we used a TAD-deficient RelA molecule. When overexpressed in T cells, this truncated RelA molecule forms homo-and heterodimers with p50 that bind to kB motifs. We found that TAD-deficient RelA has no intrinsic transcriptional activity and inhibited p65FL-dependent transcription in 293 T cells. In addition, we evaluated the regulation of the expression level, by p65TAD, of 16 genes that contain NF-kB-binding sites in their promoter region. [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] Among the different genes tested, the expression level of genes known to be regulated by p65 such as IkBa and CD69 was significantly downmodulated by expression of transactivation domain-deficient RelA, while expression of genes regulated by cRel (IL-2, CD25 and Bfl1), or not affected in NF-kB-deficient T cells (cRel, p50 and Bcl-2), remained unaltered. 5, 6, 8, 14, 16, 17, 29, 36 In all cases analyzed, the decrease in protein expression was comparable to that of mRNA. Collectively, these results suggest that, in vivo, TADdeficient RelA binds to and selectively inhibits transcription from RelA-binding sites.
Our study also reveals novel targets of RelA regulation. Thus, we found that TCR-mediated induction of FasL expression is slightly decreased in CD8
þ Des þ T cells overexpressing p65TAD. This suggests that RelA-containing complexes, although not essential, may either directly or indirectly optimize FasL transcription. In agreement with our observation, two p50/p65-binding sites are found in the þ Des þ T cells were infected with mock, p65FL or p65TAD encoding retrovirus as described in Figure 2 . At day 5 postactivation, the infected CD8 þ Des þ T cells were collected and the total, unsorted population was adoptively transferred into irradiated syngeneic B10.BR mice. Adoptively transferred mice were immunized with H-2K b -expressing B-cell blasts (immunized) or injected with PBS (unimmunized). 33 We also show that Bcl xL expression is substantially downregulated in T cells transduced with p65TAD. The regulation of Bcl xL expression in activated T cells is clearly dependent on NF-kB. 8, 17 Our results show that RelA, directly or indirectly, has a critical role in this process.
In this study, we evaluated the role of RelA in sustaining the activation of naive CD8 T cells, during restimulation of effector cells and for homeostasis of Ag-experienced T cells. We found that overexpression of TAD-deficient RelA in 22 hactivated CD8 T cells did not significantly block cell cycle progression during a primary in vitro response (Figure 3c ). In addition, p65TAD expression did not impair cell cycle progression or initial proliferation induced by restimulation of effector cells ( Figure 5 ). However, we found that overexpression of TAD-deficient RelA led to increased death of CD8 T cells during primary responses in vitro (Figure 3b ). These observations suggest that RelA regulates a critical survival step during cell cycle progression or cell cycle exit of Ag-stimulated T cells. Such a role of RelA in the survival of cycling cells is supported by our in vivo studies that show that the clonal expansion of preactivated CD8 T cells overexpressing TAD-deficient RelA either during homeostatic proliferation or at day 7 postimmunization was significantly impaired (Figures 4 and 6) . TAD-deficient RelA did not, however, affect the long-term survival of Ag experienced T cells, suggesting that RelA may be dispensable for resting effector T-cell homeostasis ( Figure 5 ). The phenotype of CD8 T cells overexpressing TAD-deficient RelA is very similar to that of mature T cells expressing a degradation-resistant IkBa, further suggesting that RelA-containing complexes are critical regulators of T-cell survival. 5, 7, 8 Interestingly however, in addition to increased apoptosis, cell cycle entry of p50
À/À T cells is significantly reduced. 17 None of the conventional NF-kB complexes (RelA, cRel and p50 homoor heterodimers) were detected in nuclear extracts from p50 À/ À cRel À/À T cells that predominantly express p52-containing complexes. 17 Since cell cycle entry is not affected by overexpression of TAD-deficient RelA or degradation-resistant IkBa, inhibition of this process in p50 À/À cRel À/À T cells is likely due to expression of p52-containing complexes.
The mechanism(s) by which RelA may regulate the fate of activated T cells is still unknown. Fas is an important inducer of activated T-cell death both in vitro and in vivo. 37, 38 Susceptibility to Fas-mediated death is, however, not increased by overexpression of TAD-deficient RelA (not shown). In addition to Fas-mediated apoptosis, several additional TCR-induced death pathways that are regulated by different antiapoptotic molecules have been described. Wan and DeGregori 7 recently showed that p73, a p53 family member whose expression is regulated by NF-kB, promotes apoptosis of cycling T cells. We found normal expression of p73 in CD8 T cells transduced with TAD-deficient RelA, suggesting that this pathway may not be involved in our experimental system. Previous studies 7, 8, 19, 29, 39 have suggested that NF-kB regulates the expression of the antiapoptotic molecules Bcl-2, Bcl-x L or Bfl1. We found a significant reduction in Bcl-x L expression, while expression of Bcl-2 or Bfl1 was not significantly diminished in T cells overexpressing TAD-deficient RelA. Several studies suggest that the prosurvival Bcl-2 family members Bcl-2 and Bcl-x L are critical regulators of activated T-cell survival during the contraction phase of an immune response in vivo. 40, 41 Further experiments are needed to determine whether death of p65TAD-expressing CD8
þ Des þ T cells results from decreased Bcl-x L expression or other mechanisms.
Previous studies have highlighted the role of NF-kB in protecting T cells from activation-induced cell death. Our study extends these observations and shows that NF-kB regulates survival of T cells during initial activation but also at later phases of the programmed proliferation. Interestingly however, NF-kB may be dispensable for survival of resting naïve, resting effector and memory cells, suggesting that NFkB controls survival of cycling T cells ( 7, 8 and this study). Finally, our results suggest that, as observed for other cell types, among the different NF-kB family members, RelA has a critical role in the regulation of activated T cells survival.
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Materials and Methods
Mice and adoptive transfer
The Désiré (Des, 47 ) transgenic mice were maintained on a B10.BR background. For adoptive transfer, B10.BR mice were g-irradiated at 7 Gy and injected i.v. with 5 Â 10 6 T cells 3 days later. When indicated, mice were immunized by intravenous injection of 5 Â 10 6 24 h-activated LPS blasts derived from C57Bl/6 mice.
Retroviral vectors, transfection and retroviral infections
Full length (p65FL) and a fragment corresponding to amino acid 1-310 (p65TAD) of human RelA were subcloned into the bicistronic pMX-EGFP retroviral vector (generous gift from Arai 48 ) that contains an IRES-EGFP. To generate retroviral particles, the PlatE packaging cell line (generous gift from Kitamura, 49 ) was transfected with the different constructs. CD8 þ T cells were purified from Désiré transgenic mice by negative selection as previously described. 50 5 Â 10 5 T cells were stimulated for 22 h with 1 Â 10 6 T-cell-depleted splenocytes from B6 mice as APC, then infected with retrovirus-containing supernatants as previously described. 51 Infected cells were maintained in IL-2 (50 U/ml)-containing medium.
For transient transfection, 293 T cells were transfected using Lipofectamine PLUS (Life Technology, Grand Island, NY, USA) with either of the three different retroviral constructs described above and an NF-kB reporter plasmid corresponding to three kB sites from the Igk promoter regulating the expression of the luciferase gene. Luciferase activity was read 24 h after transfection as previously described. 50 
Antibodies and FACS staining
Allophycocyanin-conjugated anti-CD8 Ab and PE-conjugated streptavidin were purchased from Pharmingen (Pharmingen, LaJolla, CA, USA). The Désiré anti-clonotype (Des) was prepared and biotinylated at the Centre d'Immunologie de Marseille Luminy. For cell cycle analysis, cells were fixed with 2% paraformaldehyde, then incubated with 200 mg/ml RNase A (USB, Cleveland, OH, USA) and 20 mg/ml propidium iodide (SigmaAldrich, St. Louis, MO, USA). Cell cycle analysis was performed using FlowJo software and the two-population algorithm.
Protein extract, EMSA and Western blot
Cytoplasmic and nuclear extracts were prepared as previously described. 50 EMSA were performed using double-stranded NF-kB oligonucleotides derived from the mouse CD25 promoter (5 0 -GGAACGG-CAGGGGAATTCCCCTCCTT-3 0 ) in the presence or absence of blocking Ab as previously described. 50 In total, 8-10 mg of cytoplasmic extracts were analyzed by Western blotting as previously described. 50 Ab used for supershifts or Western blots were sc-109 that is specific for the amino-terminal domain of NF-kB RelA, the p50-specific Ab sc-1192, the cRel-specific Ab sc-71, the IkBa-specific Ab sc371, the IkBb-specific Ab sc945, the Bcl-2-specific Ab sc-492, Bcl-x L -specific Ab sc-634 and Bcl-3-specific Ab sc-185 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) and an anti-actin Ab (Sigma). The different blots were quantified with a luminescent image analyzer (LAS-1000 plus; Fuji). Measured values were corrected for loading differences based on the actin signal. Results are expressed as ratio of the relative quantitation value of the sample divided by the mock.
RNA preparation and quantitative RT-PCR
Total RNA was extracted using the High Pure RNA Isolation kit (Qiagen, Valencia, USA) and cDNA was synthetized as previously described. 52 Real-time PCR was performed on cDNA samples using the Quantitectt SYBR s Green system (Qiagen). The primer sequences and cycling conditions are available upon request. Analysis used the sequence detection software supplied with the instrument. The relative quantitation value is expressed as 2 ÀDC T where DC T is the difference between the mean C T value of duplicates of the sample and of the endogenous HPRT control. Results are expressed as ratio of the relative quantitation value of the sample divided by the mock.
